7OHyea Announces Launch of MGM-15 Research Product for Canadian Analytical and Laboratory Applications

TORONTO, Sept. 04, 2026 (GLOBE NEWSWIRE) -- 7OHyea, a Canada-based supplier of research-grade alkaloid materials, has announced the launch of its 30mg MGM-15 product in Cherry, expanding the company's portfolio of specialized materials for laboratory and analytical research applications.

The newly introduced MGM-15 product is positioned as a kratom-derived modified alkaloid material rather than a conventional whole-leaf kratom extract. The launch adds another specialized compound to 7OHyea's existing research-oriented portfolio, which includes 7-hydroxymitragynine (7-OH), mitragynine and other alkaloid materials.

Traditional kratom extracts are complex mixtures derived from Mitragyna speciosa plant material and can contain numerous naturally occurring alkaloids. Mitragynine is generally considered the predominant alkaloid in natural kratom, while 7-hydroxymitragynine occurs naturally in much smaller quantities. The composition of conventional extracts can vary depending on the plant material and extraction process.

MGM-15 differs from a conventional kratom extract in that it is presented as a more specifically defined, chemically modified kratom-derived material. As a result, it should not automatically be characterized as simply a higher-potency kratom extract. Its chemical and pharmacological characteristics may differ from those of natural kratom alkaloids.

Publicly available peer-reviewed research specifically focused on MGM-15 remains limited compared with the established scientific literature surrounding mitragynine and 7-hydroxymitragynine. For this reason, researchers evaluating MGM-15 should rely on appropriate analytical documentation and product-specific information rather than assuming that the compound has the same characteristics as traditional kratom extracts.

According to 7OHyea, the company focuses on providing research-oriented alkaloid materials in defined formats and supporting documentation. Its current catalog includes 7-OH formulation in multiple strengths, mitragynine materials, full-spectrum formulations and analytical powders, with the new MGM-15 formulation expanding the range of materials available to research customers.

The company states that applicable research materials are supported by analytical documentation, including Certificates of Analysis (COAs), allowing researchers and laboratories to review available batch-specific information when evaluating products for research purposes. 7OHyea also emphasizes Canadian sourcing and fulfillment through its Toronto-based operation.

“The addition of MGM-15 expands our research catalog and gives laboratories access to another defined-format kratom-derived material,” said Oliver, a representative of 7OHyea. “We remain focused on product identification, documentation and responsible research use.”

The 30mg MGM-15 Cherry product is now listed in the company's research catalog at 7OHyea.ca. The company continues to offer a range of research materials in different formats and strengths for laboratory and analytical applications.

7OHyea states that its products are supplied for research and laboratory purposes and are not intended for human consumption. Researchers, laboratories and institutional purchasers are responsible for determining applicable regulatory, safety and procurement requirements before acquiring or using research materials.

About 7OHyea

7OHyea is a Canada-based supplier of research-grade alkaloid materials serving laboratory and analytical research applications. The company's catalog includes 7-hydroxymitragynine, mitragynine, full-spectrum materials and emerging kratom-derived compounds in pill and powder formats.

The company focuses on defined product formats, analytical documentation and Canadian fulfillment for research customers. Its products are supplied strictly for research and laboratory purposes and are not intended for human consumption.

Media Contact:

Oliver
7OHyea
231 Carlingview Dr
Toronto, ON M9W 5E8, Canada
Email: 7ohyea@gmail.com
Phone: 416-564-7462
Website: https://www.7ohyea.ca/

Disclaimer:  This content is provided by 7OHyea. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or business advice. All investments carry inherent risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own due diligence and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any inaccuracies, misrepresentations, or financial losses resulting from the use or reliance on the information in this press release. Speculate only with funds you can afford to lose. In the event of any legal claims or concerns regarding this article, we accept no liability or responsibility. GlobeNewswire does not endorse any content on this page.

Legal Disclaimer: This media platform provides the content of this article on an "as-is" basis, without warranties or representations of any kind, express or implied. We assume no responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained herein. Any complaints, copyright issues, or inquiries regarding this article should be directed to the content provider listed above.